Caraceni, Paolo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.203
AS - Asia 239
EU - Europa 171
AF - Africa 3
Continente sconosciuto - Info sul continente non disponibili 1
SA - Sud America 1
Totale 2.618
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.202
CN - Cina 124
IT - Italia 68
SG - Singapore 64
SE - Svezia 37
VN - Vietnam 37
FI - Finlandia 19
FR - Francia 16
DE - Germania 12
IN - India 11
DK - Danimarca 7
GB - Regno Unito 6
EG - Egitto 3
UA - Ucraina 3
PH - Filippine 2
SK - Slovacchia (Repubblica Slovacca) 2
BR - Brasile 1
CA - Canada 1
EU - Europa 1
NL - Olanda 1
TR - Turchia 1
Totale 2.618
Salva come PNG Salva come JPEG
Città #
Fairfield 453
Woodbridge 257
Chandler 202
Ashburn 191
Houston 178
Cambridge 164
Seattle 160
Ann Arbor 114
Wilmington 110
San Diego 48
Singapore 48
Dong Ket 37
Beijing 31
Medford 27
Princeton 27
Padova 24
Des Moines 20
Boardman 19
Roxbury 18
Nanjing 14
Helsinki 13
Falls Church 8
Changsha 7
Rome 7
Shanghai 7
Guangzhou 6
Hebei 6
New York 6
Salerno 6
Shenyang 6
Tappahannock 5
Bologna 4
Hefei 4
Lyngby 4
Santa Clara 4
Tianjin 4
Zhengzhou 4
Aarhus 3
Jinan 3
Ketsch 3
Kharkiv 3
Los Angeles 3
Milan 3
Nanchang 3
Alexandria 2
Banská Štiavnica 2
Dearborn 2
Dongguan 2
Kunming 2
London 2
Makati City 2
Ningbo 2
Pavia 2
Saint-Fons 2
Shimla 2
Washington 2
Absecon 1
Amsterdam 1
Augusta 1
Bari 1
Bonndorf 1
Bordeaux 1
Borås 1
Cairo 1
Dallas 1
Esslingen am Neckar 1
Fabriano 1
Florianópolis 1
Frankfurt am Main 1
Geislingen an der Steige 1
Haikou 1
Hounslow 1
Kilburn 1
Macerata 1
North York 1
Piacenza 1
Pune 1
Rockville 1
Stockholm 1
Taizhou 1
Venezia 1
Verona 1
Wandsworth 1
Yenibosna 1
Totale 2.316
Salva come PNG Salva come JPEG
Nome #
Assessment of Sepsis-3 criteria and quick SOFA in patients with cirrhosis and bacterial infections 156
Terlipressin plus albumin versus midodrine and octreotide plus albumin in the treatment of hepatorenal syndrome: A randomized trial 155
Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial 147
Addressing Profiles of Systemic Inflammation Across the Different Clinical Phenotypes of Acutely Decompensated Cirrhosis 132
Epidemiology and Effects of Bacterial Infections in Patients With Cirrhosis Worldwide 119
Systemic inflammation in decompensated cirrhosis: Characterization and role in acute-on-chronic liver failure 116
The PREDICT study uncovers three clinical courses in acutely decompensated cirrhosis with distinct pathophysiology 109
Strategies to Restore Adenosine Triphosphate (ATP) Level After More than 20 Hours of Cold Ischemia Time in Human Marginal Kidney Grafts 106
The CLIF Consortium Acute Decompensation score (CLIF-C ADs) for prognosis of hospitalised cirrhotic patients without acute-on-chronic liver failure 104
Multidrug-resistant bacterial infections in patients with decompensated cirrhosis and with acute-on-chronic liver failure in Europe 103
AISF-SIMTI Position Paper: The appropriate use of albumin in patients with liver cirrhosis 102
Development and validation of a prognostic score to predict mortality in patients with acute-on-chronic liver failure 98
Blood metabolomics uncovers inflammation-associated mitochondrial dysfunction as a potential mechanism underlying ACLF 96
The Italian compassionate use of sofosbuvir in HCV patients waitlisted for liver transplantation: A national real-life experience 95
Extended infusion of β-lactams for bloodstream infection in patients with liver cirrhosis: an observational multicenter study 95
Specific issues concerning the management of patients on the waiting list and after liver transplantation 92
AISF-SIMTI position paper: The appropriate use of albumin in patients with liver cirrhosis 91
A Prospective Multicentre Study of the Epidemiology and Outcomes of Bloodstream Infection in Cirrhotic Patients 91
A meta-analysis of single HCV-untreated arm of studies evaluating outcomes after curative treatments of HCV-related hepatocellular carcinoma 88
Successful Treatment of CCL4-Induced Acute Liver Failure With Portal Vein Arterialization in the Rat 84
Protective Effect of Portal Vein Arterialization in Acute Liver Failure Induced by Hepatectomy in Normal and Fatty Liver Rat 81
On-treatment serum albumin level can guide long-term treatment in patients with cirrhosis and uncomplicated ascites 81
Risk factors for candidemia in hospitalized patients with liver cirrhosis: a multicenter case-control-control study 72
Portal Vein Arterialization for the Treatment of Post Resection Acute Liver Failure in the Rat 70
Development and Validation of a Scoring System That Includes Corrected QT Interval For Risk Analysis of Patients With Cirrhosis and Gastrointestinal Bleeding 68
Technical Aspects of Portal Vein Arterialization for Acute Liver Failure: From Rat Lab to Man 63
ENDPOINTS AND DESIGN OF CLINICAL TRIALS IN PATIENTS WITH DECOMPENSATED CIRRHOSIS: POSITION PAPER OF THE LIVERHOPE CONSORTIUM 42
Totale 2.656
Salva come PNG Salva come JPEG
Categoria #
all - tutte 9.450
article - articoli 9.450
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.900
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020474 0 0 0 50 65 36 67 71 70 54 53 8
2020/2021599 26 73 23 26 18 32 20 71 52 90 77 91
2021/2022457 19 96 39 16 38 25 37 34 18 16 33 86
2022/2023339 73 41 4 51 49 39 1 17 39 1 18 6
2023/2024164 5 26 21 18 4 25 18 7 0 11 17 12
2024/2025103 1 44 29 29 0 0 0 0 0 0 0 0
Totale 2.656